Generic drugs in the US are too cheap to be sustainable, experts say
Science news, comment and analysis | theguardian.com,
Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of…
Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of…
WEDNESDAY, Jan. 17, 2024 (HealthDay News) — Incident use of common behavioral health medications remained relatively stable…
While new prescription rates for most medications to treat behavioral health conditions was steady during the COVID-19 pandemic…
Social media influencers and online marketing may have played a role, experts said.